Professor Pearl's group seeks to understand the structural basis for assembly, specificity and regulation of the multi-protein complexes involved in the recognition, repair and signalling of DNA ...

Researchers have identified a new target for an aggressive type of blood cancer, offering a promising treatment option that could keep patients well for longer, with fewer side effects. Scientists at ...

A new UK-based study is shedding light on a quiet but consequential problem in cancer research: whether some people have less opportunity than others to participate in clinical trials. The findings ...

The Institute of Cancer Research, London, strongly welcomes the news that the targeted drug capivasertib has been approved by the US Food and Drug Administration (FDA) for treating a type of advanced ...

A targeted cancer treatment given via a simple injection under the skin shrank tumours in more than one third of patients with recurrent and/or metastatic head and neck cancer whose disease has ...

Results from the international Phase III RAMPART trial were presented today at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting by researchers from The Institute of Cancer Research ...

Since the discovery of X-rays in 1895, radiation therapy, or radiotherapy, has made substantial advancements as a cancer treatment. It’s now responsible for approximately 40 per cent of cancer cures.

The Government has today published the National Cancer Plan, setting out a 10-year strategy to improve cancer outcomes in England through new targets and measures to accelerate diagnosis and treatment ...

Scientists have created the most comprehensive map to date of the genetic mutations that fuel cancer – opening the door to extending precision treatments to thousands more patients and offering clues ...

A new immunotherapy drug has shown promise for safely treating prostate cancer, a phase I trial reports. Almost half of the patients in the trial that could be evaluated saw their tumour shrink after ...

Professor Paul Workman has been awarded an OBE (Officer of the Order of the British Empire) in the New Year Honours list 2026 for services to cancer research. Previously Chief Executive and President ...

Experts at The Institute of Cancer Research, London, have responded to the draft recommendation from the National Screening Committee (NSC) to implement a targeted prostate cancer screening programme ...